InsurTech Investors & VC Firms in United States
326 firms in this list, with a median first check of $500K. 110 of them lead rounds. Generated from verified public data and updated continuously.
Curql Collective, LLC
Des MoinesSeed–Series A
32 people
Aquarian Holdings
New YorkLate Stage
43 people
AAF Management Ltd.
WashingtonPre-Seed–Series A
4 people
Vertical Venture Partners
Palo AltoPre-Seed–Series A$500K – $4M
16 people
Core Venture Capital
Los AngelesSeed–Series A$1M – $5M
15 people
Prototype Capital
Los AngelesPre-Seed–Seed
38 people
Odyssey Investment Partners
New YorkGrowth$100M – $300M
24 people
SemperVirens Venture Capital
San MateoPre-Seed–Series A
17 people
FUSE
BellevuePre-Seed–Series A$1M – $10M
15 people
Montage Ventures
Menlo ParkPre-Seed–Series A$4M
15 people
World Innovation Lab
Palo AltoGrowth–Late Stage
30 people
Draft Ventures Llc
San FranciscoPre-Seed–Seed
4 people
TruStage Ventures
MadisonSeed–Series A$1M – $5M
26 people
Aquiline Technology Growth
New YorkGrowth
6 people
The Hive
Santa MonicaPre-Seed–Series A$1.5M – $3M
28 people
Propel Venture Partners
San FranciscoPre-Seed–Series A$500K – $5M
12 people
Echo Health Ventures
DurhamSeed–Growth
25 people
Lobby Capital
Palo AltoSeed–Series A
14 people
Gallatin Point Capital
GreenwichSeed–Growth$50M – $200M
24 people
Stout Street Capital
DenverPre-Seed–Seed$250K
6 people
RET Ventures
Park CitySeed–Growth
18 people
AXA Venture Partners
New YorkSeed–Series C
18 people
Fenway Summer Ventures
WashingtonPre-Seed–Series A
14 people
Suffolk Technologies
BostonSeed–Series A
17 people
Related lists
Investors & VC Firms in North America (12835)Investors & VC Firms in United States (11883)Investors & VC Firms in Europe (5830)Investors & VC Firms in Global (4736)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4546)SaaS Investors & VC Firms (4222)Healthtech Investors & VC Firms (4190)Enterprise Software Investors & VC Firms (4099)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.








































































































